Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies

被引:19
|
作者
Gottsäter, A [1 ]
Forsblad, J
Mätzsch, T
Persson, K
Ljungcrantz, I
Ohlsson, K
Lindgärde, F
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Clin Microbiol, Malmo, Sweden
[3] Lund Univ, Malmo Univ Hosp, Dept Surg Pathophysiol, Malmo, Sweden
关键词
carotid artery stenosis; Chlamydia pneumoniae; interleukin-1 receptor antagonist; interleukin-1; beta; triglycerides;
D O I
10.1046/j.1365-2796.2002.00926.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate whether the interleukin-1 receptor antagonist (Il-1ra) and interleukin-1beta (Il-1beta) can be detected in human carotid artery tissue, and whether their presence is related to evidence of Chlamydia pneumoniae infection, risk factors for atherosclerosis, and clinical data. Setting. Departments of Vascular Diseases and Surgical Pathophysiology, University Hospital, Malmo, Sweden. Subjects. A total of 66 patients undergoing carotid endarterectomy (median age 74, range 53-89 years, 20 women). Il-1beta and Il-1ra were studied in carotid artery plaques and in Il-1ra in serum. Results. Interleukin-1 receptor antagonist was detected in mononuclear cells in plaques from 37/ 66 (56%) patients. Patients with Il-1ra in plaques showed higher [2.04 (1.70-3.14) mmol L-1 vs. 1.69 (1.09-1.99) mmol L-1; P < 0.05] serum(s-)triglyceride(tg) levels, and a higher frequency of IgA seropositivity for C. pneumoniae (76% vs. 52%: P < 0.05) than those without. S-Il-1ra levels correlated with s-tg levels (r = 0.38; P = 0.047). There were no differences between patients with and without Il-1ra in plaques concerning s-Il-1ra, blood(b-)haemoglobin or leucocyte count, s-cholesterol, b-glucose, blood pressure, IgG seropositivity for C. pneumoniae, prevalence of neurological symptoms preceding operation, smoking, or diabetes mellitus. There were no differences in frequency of Il-1ra in plaques or in s-Il-1ra levels between patients with symptomatic and asymptomatic stenosis, between smokers and nonsmokers, or between diabetic and nondiabetic patients. Il-1beta was not detected in plaques in the current study. Conclusion. Interleukin-1 receptor antagonist can be detected in human atherosclerotic carotid artery plaques, and is related to s-triglyceride levels and IgA seropositivity for C. pneumoniae, but not to prevalence of neurological symptoms related to embolization.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [1] Expression of interleukin-1β, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty
    Wang, XK
    Romanic, AM
    Yue, TL
    Feuerstein, GZ
    Ohlstein, EH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (01) : 138 - 143
  • [2] No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques
    Halvorsen, Dag S.
    Karlsen, Joachim
    Noto, Ann-Trude W.
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Gutteberg, Tore J.
    Vorland, Lars H.
    Hansen, John-Bjarne
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 117 (03) : 388 - 394
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR
    HANNUM, CH
    WILCOX, CJ
    AREND, WP
    JOSLIN, FG
    DRIPPS, DJ
    HEIMDAL, PL
    ARMES, LG
    SOMMER, A
    EISENBERG, SP
    THOMPSON, RC
    NATURE, 1990, 343 (6256) : 336 - 340
  • [4] Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction
    van Minkelen, Rick
    Wettinger, Stephanie Bezzina
    de Visser, Marieke C. H.
    Vos, Hans L.
    Reitsma, Pieter H.
    Rosendaal, Frits R.
    Bertina, Rogier M.
    Doggen, Carine J. M.
    ATHEROSCLEROSIS, 2009, 203 (01) : 201 - 205
  • [5] Interleukin-1 receptor antagonist gene Polymorphisms in carotid atherosclerosis
    Worrall, BB
    Azhar, S
    Nyquist, PA
    Ackerman, RH
    Hamm, TL
    DeGraba, TJ
    STROKE, 2003, 34 (03) : 790 - 793
  • [6] Circulating interleukin-1 receptor antagonist levels in neonates
    Geiger, R
    Ellemunter, H
    Fink, FM
    Falk, M
    Tilg, H
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (09) : 811 - 814
  • [7] Balance of interleukin-1β and interleukin-1 receptor antagonist in human periapical lesions
    Shimauchi, H
    Takayama, S
    Imai-Tanaka, T
    Okada, H
    JOURNAL OF ENDODONTICS, 1998, 24 (02) : 116 - 119
  • [8] Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy
    Watanabe, M
    Iwano, M
    Akai, Y
    Kurioka, H
    Nishitani, Y
    Harada, K
    Hamano, K
    Shiiki, H
    NEPHRON, 2002, 91 (04): : 744 - 746
  • [9] Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
    Mosorin, M
    Surcel, HM
    Laurila, A
    Lehtinen, M
    Karttunen, R
    Juvonen, J
    Paavonen, J
    Morrison, RP
    Saikku, P
    Juvonen, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 1061 - 1067
  • [10] Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
    Uludag, Irem Fatma
    Bilgin, Sule
    Zorlu, Yasar
    Tuna, Gamze
    Kirkali, Guldal
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (06): : 457 - 461